733 844
0
10
20
30
40
50
60
70
80
2008
2007
2006
2005
2004
2012
2011
2010
2009
PaƟents receiving ADT (%)
Year of treatment
High-risk prostate cancer
0
10
20
30
40
50
60
70
80
2008
2007
2006
2005
2004
2012
2011
2010
2009
PaƟents receiving ADT (%)
Year of treatment
Intermediate-risk prostate cancer
0
10
20
30
40
50
60
70
80
2008
2007
2006
2005
2004
2012
2011
2010
2009
PaƟents receiving ADT (%)
Year of treatment
Low-risk prostate cancer
(A)
(B)
(C)
Cryotherapy
Brachytherapy
External beam radiotherapy
Radical prostatectomy
Cryotherapy
Brachytherapy
External beam radiotherapy
Radical prostatectomy
Cryotherapy
Brachytherapy
External beam radiotherapy
Radical prostatectomy
Fig. 3 – Utilization of concomitant androgen deprivation therapy (ADT) between 2004 and 2012 for patients with (A) low-risk, (B) intermediate-risk, and (C) high-risk prostate cancer.
E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 7 2 9 – 7 3 7
733